Hyperbaric Medicine Unit, University Hospital of Brest, Bvd Tanguy Prigent, 29609 Brest Cedex, France.
Department of Cardiology, University Hospital of Brest, Bvd Tanguy Prigent, 29609 Brest Cedex, France.
Europace. 2023 May 19;25(5). doi: 10.1093/europace/euad134.
Hyperbaric oxygen therapy (HBOT) is the standard adjuvant treatment for life-threatening or disabling pathologies. Currently, mechanical and electronic variations of implantable cardioverter-defibrillators (ICD) in hyperbaric conditions have not been evaluated. As a result, many patients eligible for HBOT but ICD recipients cannot undergo this therapy, even in emergency situations.
Twenty-two explanted ICD of various brands and models were randomized in two groups: single hyperbaric exposure at an absolute pressure of 4000 hPa and 30 iterative hyperbaric exposures at an absolute pressure of 4000 hPa. Mechanical and electronic parameters of these ICD were blindly assessed before, during, and after hyperbaric exposures. Regardless of the hyperbaric exposure, we could not find any mechanical distortion, inappropriate occurrence of anti-tachycardia therapies, dysfunction of tachyarrhythmia therapeutic programming, or dysfunction of programmed pacing parameters.
Dry hyperbaric exposure seems harmless on ICD tested ex vivo. This result may lead to a reconsideration of the absolute contraindication of emergency HBOT to ICD recipients. A real-life study in these patients with an indication to HBOT should be performed to assess their tolerance to the treatment.
高压氧治疗(HBOT)是治疗危及生命或致残性疾病的标准辅助治疗方法。目前,在高压环境下植入式心脏复律除颤器(ICD)的机械和电子变化尚未得到评估。因此,许多符合 HBOT 条件但同时也是 ICD 接受者的患者无法进行这种治疗,即使在紧急情况下也是如此。
将来自不同品牌和型号的 22 个已植入的 ICD 随机分为两组:在绝对压力为 4000 hPa 的条件下进行单次高压暴露和在绝对压力为 4000 hPa 的条件下进行 30 次迭代高压暴露。在高压暴露之前、期间和之后,对这些 ICD 的机械和电子参数进行了盲法评估。无论进行何种高压暴露,我们都未发现任何机械变形、抗心动过速治疗的不当发生、心动过速治疗编程功能障碍或程控起搏参数功能障碍。
体外测试表明,干燥的高压暴露对 ICD 似乎无害。这一结果可能导致重新考虑将紧急 HBOT 对 ICD 接受者的绝对禁忌。应在这些有 HBOT 适应证的患者中进行真实世界的研究,以评估他们对治疗的耐受性。